← Back to Patent Explorer
US4495288A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of culturing anchorage dependent cells

Assignee: Abbott Biotech Inc
•
Filing: 1983-04-13
•
Granted: 1985-01-22
•
Expires: 2003-04-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a method of growing anchorage-dependent cells: cells of the type which normally undergo mitosis only when anchored on a substrate, e.g., fibroblasts or epithelial cells. The method comprises the steps of encapsulating a seed culture of the cells within a semipermeable membrane and suspending the capsules in a growth medium. The interior surfaces of the capsule membrane and/or collagen enclosed within the capsules serve as a substrate for the cells. The ratio of the available substrate surface area to the volume of the culture may be large, thereby allowing the cells to be grown substantially throughout the volume of the culture medium.

Inventors

  • 👤 Allan P. Jarvis, Jr.
  • 👤 Franklin Lim

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:20
CPC Classifications
C; C12; C12P; C12P21/00; C12P21/02; C12N; C12N5/00; C12N5/0012; C12N2533/00; C12N2533/50; C12N2533/54; C12N2533/70; C12N2533/74; Y; Y10; Y10S; Y10S623/00; Y10S623/915

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 143 words
A process for culturing anchorage dependent cells, said process comprising the steps of: A. suspending a cell in a medium containing an anchorage substrate material and high molecular weight components needed to maintain viability and to support mitosis of said cell; B. encapsulating said cell together with said medium and anchorage substrate material within a semipermeable membrane comprising a polysaccharide having plural anionic groups cross-linked with a polymer having plural cationic groups and a molecular weight greater than 3,000, said semipermeable membrane having an upper limit of permeability sufficient to preclude traverse of said anchorage substrate material and sufficient to allow low molecular weight molecules to traverse said membrane; C. suspending the product of step B in a culture medium sufficient to maintain viability and to support mitosis of said encapsulated cell; and D. allowing said cell to undergo mitosis within said membrane.
Claim 2
Dependent Claim 143 words
A process for culturing anchorage dependent cells, said process comprising the steps of: A. suspending a cell in a medium containing an anchorage substrate material and high molecular weight components needed to maintain viability and to support mitosis of said cell; B. encapsulating said cell together with said medium and anchorage substrate material within a semipermeable membrane comprising a polysaccharide having plural anionic groups cross-linked with a polymer having plural cationic groups and a molecular weight greater than 3,000, said semipermeable membrane having an upper limit of permeability sufficient to preclude traverse of said anchorage substrate material and sufficient to allow low molecular weight molecules to traverse said membrane; C. suspending the product of step B in a culture medium sufficient to maintain viability and to support mitosis of said encapsulated cell; and D. allowing said cell to undergo mitosis within said membrane.
Claim 3
Dependent Claim 12 words
The process of claim 1 wherein said anchorage substrate is a protein.
Claim 4
Dependent Claim 11 words
The process of claim 1 wherein said anchorage substrate is collagen.
Claim 5
Dependent Claim 29 words
The process of claim 1 wherein the anchorage substrate is calf skin collagen and is included in said suspension at a concentration between about 10 ug/ml and 1.0 mg/ml.
Claim 6
Dependent Claim 21 words
The process of claim 1 comprising the additional step of selectively disrupting said membranes after step D to release said cells.
Claim 7
Dependent Claim 11 words
The process of claim 1 wherein said cell comprises a fibroblast.
Claim 8
Dependent Claim 14 words
The process of claim 1 wherein said high molecular weight components comprise serum components.
Claim 9
Dependent Claim 16 words
The process of claim 1 wherein said cell comprises a human fibroblast capable of secreting interferon.
Claim 10
Dependent Claim 24 words
The process of claim 1 wherein during said encapsulation step spheroidal membranes having an average diameter in the range of 100-500 microns are produced.
Claim 11
Dependent Claim 17 words
The process of claim 1 wherein said anchorage substrate comprises a protein having plural free cationic groups.

References Cited (Backward Citations)

US3730841A Cited
US4189534A Cited
GB2046209A Cited
US4352883A Cited
US4266032A Cited
GB2083827A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-01-22 1988-07-23 1989-01-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-01-22 1992-07-23 1993-01-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-01-22 1996-07-23 1997-01-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag